Is it possible that Pfizer, in its all-out sprint to bring the first-ever human mRNA vaccine to market, ended up delivering the second-best product? Shane Crotty, a researcher at the La Jolla Institute for Immunology, told me that after looking at some of the recent data, he went to double-check his own vaccination record and was pleased to find Moderna listed on it. “It’s very hard to compare two very effective interventions.” Other experts see the evidence of a difference, however slight, starting to grow. “All of the real-world evidence you have to take with caution,” Pfizer’s chief scientific officer, Mikael Dolsten, told me recently. Recipients of Moderna’s shots, after all, may also need a booster eventually. Pfizer’s shots remain highly protective against hospitalization, but the latest numbers from the CDC suggest that their effectiveness has dropped from 87 percent to 80 percent during the Delta wave, while that of Moderna’s shots remains in the 90s.Īlthough Pfizer has now sold authorities around the world on the imminent need for third shots to combat waning immunity, the company doesn’t believe that its vaccine, worth more than $30 billion to its bottom line, is inferior in any way to competitors.
Compared with Moderna’s competing shot, Pfizer’s vaccine seems to induce half the amount of virus-fighting antibodies, and is associated with nearly twice as many breakthrough infections, according to two recent studies. Visit ups.com/healthcare.The Delta variant’s arrival this summer delivered a blow to the nation’s entire coronavirus arsenal, but its impact on the champion of last year’s vaccine race-Pfizer-has been particularly humbling. UPS Healthcare’s global infrastructure, its newest UPS Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today’s complex logistics demands for the pharmaceutical, medical device and laboratory diagnostic industries.
#Pfizer operation warp speed trial#
UPS Healthcare services include: inventory management, temperature-controlled packaging and shipping, storage and fulfillment of medical devices, labs and clinical trial logistics. UPS Healthcare operates 128 facilities in 32 countries which are regulated under Good Manufacturing Practices (GMP). “We know that agile, world-class logistics is critical to get our products where they are needed, and we’re happy to partner with UPS in this historic effort to save lives and create healthier communities right now and well into the future.” “This is undoubtedly a historic feat not only for vaccine development but also expedient deployment,” says Mike McDermott, President, Pfizer Global Supply. The vaccines will be transported to UPS Worldport facilities in Louisville, where they will be expedited Next Day Air to select destinations, including hospitals, clinics and other medical facilities, to inoculate healthcare workers. Pfizer-BioNTech COVID-19 vaccines will originate from storage sites in Michigan and Wisconsin. “We have spent months strategizing with Operation Warp Speed officials and our healthcare customers on efficient vaccine logistics, and the time has arrived to put the plan into action.” “This is the moment of truth we’ve been waiting for at UPS,” says Wes Wheeler, president of UPS Healthcare. based on orders received by Operation Warp Speed and CDC officials. UPS will move the Pfizer-BioNTech COVID-19 vaccine within the first days to states designated by Pfizer, Inc. We’re pleased to support our healthcare partners with smart, efficient logistics for these vaccines that will protect communities and save lives.” “We have dedicated and hardworking people around the world who have been trained to store, handle, transport and deliver vaccines. “Vaccine distribution is a key part of moving our world forward by delivering what matters,” says Carol Tomé, CEO of UPS. Food and Drug Administration emergency use authorization (EUA), is the first to be deployed in a months-long global race to develop safe vaccines to combat the spread of the COVID-19 virus. Pfizer’s and BioNTech’s vaccine, approved through a U.S.
#Pfizer operation warp speed full#
UPS (NYSE:UPS) today announced its involvement and full support of distribution efforts for Pfizer-BioNTech’s COVID-19 vaccine as part of Operation Warp Speed.
0 kommentar(er)
